Veripel SR - Mebeverine Hydrochloride | VetSafeCare.Com

Brand

Veripel SR

Mebeverine Hydrochloride — Beacon Pharmaceuticals Ltd.
200mg / capsule (sustained release)

Alternatives

18

Routes

PO

Presentations

1

Generic profile Browse alternatives View combinations

Presentations

Capsule (Sustained Release) · 200mg / capsule (sustained release)

1 capsule (sustained release)

৳9.03

Dose rules

No structured dose rules are linked to this brand yet.

Dose reference

Human

For adults, elderly and children over 10 years: Mebeverine Hydrochloride 135 mg tablet: 1 tablet 03 times daily. Mebeverine Hydrochloride 200 mg capsule: 1 capsule 02 times daily. This is most effective when taken 20 minutes before meals. After several weeks when the desired effect has been obtained, the dosage may be gradually reduced.Missed dose: If a dose of this medicine is missed, that should be taken as soon as possible. However, if it is almost time for the next dose, then skip the missed dose and the regular dosing schedule should be maintained. Dose should not be doubled at the same time to compensate the missed dose.Use in children: Mebeverine is not recommended for children under 10 years.

Clinical notes

Applications:

N/A

Indication Notes:
Mebeverine is indicated for the: Symptomatic treatment of irritable bowel syndrome (IBS) Chronic irritable colon Spastic constipation Mucous colitis Colicky abdominal pain Persistent non-specific diarrhoea
Avoid In:

N/A

Contraindication Notes:
Hypersensitivity to the drug or any other ingredients.
Generally Mebeverine is well tolerated. However, few side-effects like skin rash, urticaria and angioedema may appear
On theoretical grounds it may be predicted that CNS excitability will occur in case of overdosage. No specific antidote is known: gastric lavage and symptomatic treatment is recommended
No teratogenicity has been shown in animal experiments. However, the usual precautions concerning the administration of any drug during pregnancy should be exercised. Mebeverine does not excrete in the breast milk after administering at therapeutic dose.
Caution should be exercised in porphyria or allergic reaction to this or any other medicine of this group.